These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9739497)

  • 1. Therapy and clinical trials.
    Cramb R
    Curr Opin Lipidol; 1998 Aug; 9(4):381-3. PubMed ID: 9739497
    [No Abstract]   [Full Text] [Related]  

  • 2. Currently available lipid-lowering agents.
    Levy RI
    Hosp Pract (Off Ed); 1988 Jun; 23 Suppl 1():14-21. PubMed ID: 3134381
    [No Abstract]   [Full Text] [Related]  

  • 3. Making the most of cholesterol-lowering margarines.
    Avery JK
    Cleve Clin J Med; 2001 Mar; 68(3):194-6. PubMed ID: 11263847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diet therapy for hypercholesteremia and hypertriglyceridemia. 1st results of a campaign for the prevention of atheroscloerosis].
    Poncelet L; Dezangre D; Collin B; Gillot P; Graulich P; Vanderveiken F; Vastesaeger M
    Brux Med; 1975 May; 55(5):263-74. PubMed ID: 1097057
    [No Abstract]   [Full Text] [Related]  

  • 5. The ineffectiveness of a commonly recommended lipid-lowering diet in significantly lowering the serum total and low-density lipoprotein cholesterol levels.
    Roberts WC
    Am J Cardiol; 1994 Mar; 73(8):623-4. PubMed ID: 8147319
    [No Abstract]   [Full Text] [Related]  

  • 6. Dietary and pharmacologic therapy for the lipid risk factors.
    JAMA; 1983 Oct; 250(14):1873-9. PubMed ID: 6620484
    [No Abstract]   [Full Text] [Related]  

  • 7. Dyslipidemia: drugs, diet, and common sense.
    Kuritzky L
    Hosp Pract (Off Ed); 1994 Aug; 29(8):40-1, 44. PubMed ID: 8056857
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapy and clinical trials.
    Curr Opin Lipidol; 1997 Dec; 8(6):B77-85. PubMed ID: 9412779
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of intensive diet and exercise intervention in patients taking cholesterol-lowering drugs.
    Barnard RJ; DiLauro SC; Inkeles SB
    Am J Cardiol; 1997 Apr; 79(8):1112-4. PubMed ID: 9114776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of hyperlipidemia. Diet and drugs.
    Steinberg D; Grundy SM
    Arch Surg; 1978 Jan; 113(1):55-60. PubMed ID: 619861
    [No Abstract]   [Full Text] [Related]  

  • 11. Practical drug therapy for common hyperlipidaemias.
    Tikkanen MJ
    Baillieres Clin Endocrinol Metab; 1990 Dec; 4(4):719-42. PubMed ID: 2082904
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharma clinics. Drug of the month. Acipimox (Olbetam)].
    Scheen AJ
    Rev Med Liege; 1995 Nov; 50(11):489-90. PubMed ID: 8532997
    [No Abstract]   [Full Text] [Related]  

  • 13. Physician's office guide to a lipid-lowering diet.
    Greene JM; Feldman EB
    J Am Coll Nutr; 1991 Oct; 10(5):443-52. PubMed ID: 1659592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of hyperlipidemia: whether, rather than how.
    Ahrens EH
    Ann Intern Med; 1976 Jul; 85(1):87-93. PubMed ID: 779574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of several hypolipidemic agents related to clofibrate.
    Beaumont V; Buxtorf JC; Jacotot B; Beaumont JL
    Atherosclerosis; 1974; 20(2):141-53. PubMed ID: 4369878
    [No Abstract]   [Full Text] [Related]  

  • 16. Some aspects of the management of the hyperlipidaemias.
    Rowe WS
    Med J Aust; 1975 May; 1(18):563-5. PubMed ID: 1143148
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of a new niacin derivative (nicotinic hexaester of D-glucitol) on type IIA, IIB and IV hyperlipoproteinemia in man.
    Avogaro P; Bittolo-Bon G; Pais M; Taroni GC
    Pharmacol Res Commun; 1977 Jun; 9(6):599-606. PubMed ID: 197548
    [No Abstract]   [Full Text] [Related]  

  • 18. Focus on fenofibrate.
    Brown WV
    Hosp Pract (Off Ed); 1988 Jun; 23 Suppl 1():31-40. PubMed ID: 3134383
    [No Abstract]   [Full Text] [Related]  

  • 19. Selection of appropriate type and intensity of lipid-lowering therapy.
    Tikkanen MJ
    Curr Opin Lipidol; 1995 Dec; 6(6):360-4. PubMed ID: 8750248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trials of lipid-lowering therapy in secondary prevention of coronary heart disease.
    Olsson AG; Pedersen T; Bergdahl B
    Curr Opin Lipidol; 1995 Dec; 6(6):369-73. PubMed ID: 8750250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.